Prolactinoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) No edit summary |
YazanDaaboul (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{Faizan}} | {{CMG}} {{AE}}{{Faizan}} | ||
==Overview== | ==Overview== | ||
The prevalence of prolactinoma in younger age group is 100 per 100,000 individuals worldwide.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> Clinically significant pituitary [[tumors]] affect approximately 14 out of 100,000 people in United States. | The prevalence of prolactinoma in younger age group is 100 per 100,000 individuals worldwide.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> Clinically significant pituitary [[tumors]] affect approximately 14 out of 100,000 people in United States. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | |||
*The [[prevalence]] of prolactinoma in younger age group is 100 per 100,000 individuals worldwide.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> | *The [[prevalence]] of prolactinoma in younger age group is 100 per 100,000 individuals worldwide.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> | ||
*Clinically significant [[pituitary]] tumors affect the health of approximately 14 out of 100,000 people in United States. | *Clinically significant [[pituitary]] tumors affect the health of approximately 14 out of 100,000 people in United States. | ||
Revision as of 16:58, 15 September 2015
|
Prolactinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prolactinoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Prolactinoma epidemiology and demographics |
|
Risk calculators and risk factors for Prolactinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
The prevalence of prolactinoma in younger age group is 100 per 100,000 individuals worldwide.[1] Clinically significant pituitary tumors affect approximately 14 out of 100,000 people in United States.
Epidemiology and Demographics
Prevalence
- The prevalence of prolactinoma in younger age group is 100 per 100,000 individuals worldwide.[1]
- Clinically significant pituitary tumors affect the health of approximately 14 out of 100,000 people in United States.
- Some growth hormone producing tumors also co-secrete prolactin.
- Microprolactinomas are much more common than macroprolactinomas.
Age
Prolactinomas occur more often in adolescents. It rarely occur in children.
Gender
Prolactinomas occur more often in women than men.
References
- ↑ 1.0 1.1 Ciccarelli A, Daly AF, Beckers A (2005). "The epidemiology of prolactinomas". Pituitary. 8 (1): 3–6. doi:10.1007/s11102-005-5079-0. PMID 16411062.